Cite
HARVARD Citation
Ogawa, E. et al. (2020). Ledipasvir and sofosbuvir for 12 weeks for hepatitis C virus genotype 2 infection: A propensity score matched analysis. Hepatology research. 50 (2), pp. 174-181. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ogawa, E. et al. (2020). Ledipasvir and sofosbuvir for 12 weeks for hepatitis C virus genotype 2 infection: A propensity score matched analysis. Hepatology research. 50 (2), pp. 174-181. [Online].